Erythema Clinical Trial
Official title:
Effect of Thoracic Spine Mobilization on Skin-blood Flow, Erythema and Sympathetic Nervous Systems
Verified date | January 2019 |
Source | Bern University of Applied Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This pilot study aims to i) represents the feasibility of the study design and ii) to point out acute effects of thoracic spine mobilization on skin-blood flow, erythema and the sympathetic nervous system.
Status | Completed |
Enrollment | 14 |
Est. completion date | December 31, 2018 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 30 Years |
Eligibility |
Inclusion Criteria: - age 20 - 30 years - healthy persons Exclusion Criteria: - current pain - blood pressure medications - osteoporosis - cardiac or neurological symptoms - pregnancy - thromobosis |
Country | Name | City | State |
---|---|---|---|
Switzerland | Bern University of Applied Science, Department Health | Bern |
Lead Sponsor | Collaborator |
---|---|
Bern University of Applied Sciences |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility: Adherence of recruited participants | Defined as the number of drop-outs and presence of participants which invited. Measurement unit: number | Every 4 weeks up to 2 years | |
Primary | Feasibility of the investigating procedure | Measured the burden of testing procedure. Measurement units = number and percentage | Every 4 weeks up to 2 years | |
Primary | Feasibility of the mobilization intervention from posterior-to-anterior on thoracic vertebrae | Measured adverse effects as pain and harm results to participants. Measurement units = number and percentage | Every 4 weeks up to 2 years | |
Primary | Feasibility of the mobilization intervention from anterior-to-posterior on thoracic vertebrae | Measured as adverse effects as pain and harm results to participants. Measurement units = number and percentage. | Every 4 weeks up to 2 years | |
Secondary | Rate of heart rate variability (HRV) | HRV is measured as the variations of the time interval between two consecutive cardiac beats registered by means Polar watch RS800 is used to measures (HRV). Measurement unit: High frequency-band (HF-Band) and Low frequency-band (LF-Band) | Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention | |
Secondary | Rate of systolic blood pressure value (mmHg) | Omron MIT Elite Plus is used for measuring systolic blood flow. iMeasurement units: mmHg (millimeter of mercury) | Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention | |
Secondary | Rate of diastolic blood pressure value (mmHg) changes | Omron MIT Elite Plus is used for measuring diastolic blood pressureMeasurement units: mmHg (millimeter of mercury) | Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention | |
Secondary | Rate of heartbeat frequency | Polar watch RS800 is used for measuring heartbeat frequency. Measurement units: beat per minute (bpm) | Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention | |
Secondary | Rate of skin-blood flow variation | Laser doppler imaging is used for measuring microcirculatory changes. Measurement units: perfusion unit | Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention | |
Secondary | Rate of erythema | Tristimulus surface colorimetry is used for measuring erythema. Measurement units: Erythema index | Change from baseline imediately after, 2, 4, 6, 8 and 10 minutes after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04290273 -
Characterisation of the Time-course Response of UV-induced Erythema
|
N/A | |
Completed |
NCT01659853 -
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
|
Phase 3 | |
Completed |
NCT00839462 -
Efficacy of Dexpanthenol in Thermic Erythema
|
Phase 2 | |
Not yet recruiting |
NCT06016361 -
Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy
|
N/A | |
Completed |
NCT03633877 -
Durapore vs. Hy-Tape to Secure The Endotracheal Tube
|
N/A | |
Active, not recruiting |
NCT02876107 -
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
|
Phase 2 | |
Completed |
NCT06369675 -
Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design
|
Phase 1 | |
Completed |
NCT03352323 -
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
|
Phase 3 | |
Completed |
NCT06369727 -
Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design
|
Phase 1 | |
Completed |
NCT03041064 -
Multiday Beach Study
|
N/A | |
Completed |
NCT02131636 -
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
|
Phase 3 | |
Terminated |
NCT01597921 -
A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer
|
N/A | |
Completed |
NCT01636765 -
Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale
|
||
Completed |
NCT01124513 -
Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI
|
N/A | |
Terminated |
NCT03496584 -
Effects of Phytonutrients on Vascular Health and Skin in Obese Males
|
N/A | |
Completed |
NCT02737592 -
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
|
N/A | |
Completed |
NCT03852563 -
A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering
|
N/A | |
Completed |
NCT05300542 -
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
|
N/A | |
Completed |
NCT03477825 -
Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
|
N/A | |
Completed |
NCT02490943 -
A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS
|
N/A |